Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Fassan

Showing results (31-40 of 642) with videos related to

Pageof 65
Sort By:
Pancreas|July 14, 2020
Pancreatic Neuroendocrine Neoplasms and Gastrointestinal Stromal Tumors: A Single-Institution Experience of a Rare Association and Review of the LiteratureAnna Caterina Milanetto, Sabrina Pacciani, Matteo Fassan, et al.
World Journal of Gastroenterology|July 29, 2016
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practiceFederica Grillo, Matteo Fassan, Francesca Sarocchi, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Coronary Artery Disease and Gallbladder Inflammatory PseudopolypsMargherita Fosio, Giulia Cherobin, Roberto Stramare, et al.
Gastrointestinal Endoscopy|October 8, 2023
Buried esophageal adenocarcinoma after radiofrequency ablation with pagetoid spreadingMarco Pocci, Rita Alfieri, Matteo Fassan, et al.
Clinical Colorectal Cancer|October 26, 2025
B7-H3 in Colorectal Adenocarcinoma: Are We Focusing on the Right Target?Paola Parente, Davide Ciardiello, Valentina Angerilli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
Gut|September 2, 2019
There is much more to rely on histology than the sole endoscopy tells usMatteo Ghisa, Massimo Rugge, Matteo Fassan, et al.
Current Pharmaceutical Design|October 25, 2012
MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic optionsMatteo Fassan, Raffaele Baffa, Andras Kiss, et al.
Internal and Emergency Medicine|May 30, 2023
Gut inflammation and tumorigenesis: every site has a different tale to tellAlessandro Vanoli, Paola Parente, Matteo Fassan, et al.
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in the management of metastatic bladder cancerMatteo Fassan, Edouard J Trabulsi, Leonard G Gomella, et al.
Pageof 65

Showing results (31-40 of 642) with videos related to

Sort By:
Pageof 65
Pancreas|July 14, 2020
Pancreatic Neuroendocrine Neoplasms and Gastrointestinal Stromal Tumors: A Single-Institution Experience of a Rare Association and Review of the LiteratureAnna Caterina Milanetto, Sabrina Pacciani, Matteo Fassan, et al.
World Journal of Gastroenterology|July 29, 2016
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practiceFederica Grillo, Matteo Fassan, Francesca Sarocchi, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Coronary Artery Disease and Gallbladder Inflammatory PseudopolypsMargherita Fosio, Giulia Cherobin, Roberto Stramare, et al.
Gastrointestinal Endoscopy|October 8, 2023
Buried esophageal adenocarcinoma after radiofrequency ablation with pagetoid spreadingMarco Pocci, Rita Alfieri, Matteo Fassan, et al.
Clinical Colorectal Cancer|October 26, 2025
B7-H3 in Colorectal Adenocarcinoma: Are We Focusing on the Right Target?Paola Parente, Davide Ciardiello, Valentina Angerilli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2016
A Triple Rare E709K and L833V/H835L EGFR Mutation Responsive to an Irreversible Pan-HER Inhibitor: A Case Report of Lung Adenocarcinoma Treated with AfatinibStefano Frega, PierFranco Conte, Matteo Fassan, et al.
Gut|September 2, 2019
There is much more to rely on histology than the sole endoscopy tells usMatteo Ghisa, Massimo Rugge, Matteo Fassan, et al.
Current Pharmaceutical Design|October 25, 2012
MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic optionsMatteo Fassan, Raffaele Baffa, Andras Kiss, et al.
Internal and Emergency Medicine|May 30, 2023
Gut inflammation and tumorigenesis: every site has a different tale to tellAlessandro Vanoli, Paola Parente, Matteo Fassan, et al.
Biologics : Targets & Therapy|August 27, 2009
Targeted therapies in the management of metastatic bladder cancerMatteo Fassan, Edouard J Trabulsi, Leonard G Gomella, et al.
Pageof 65